The cancer type with the highest proportion of FGFR3 alterations is urothelial carcinoma with a frequency of 60–80% in the non-muscle-invasive form and 15–20% in the muscle-invasive form harbouring these molecular aberrations [3,5,6,7]. This evidence concerns the gene FGFR3 and urothelial carcinoma.